Dr. Horst Christian Weber
Boston University School of Medicine, USA

Email: [email protected]

Qualifications

2007-present Associate Chief and Clinical Director, Gastroenterology VA Boston Health Care System, USA

1998-present Staff Physician, VA Boston Health Care System, USA

1997-present Staff Physician, Boston Medical Center, USA

Publications (Selected)

1. Shaikh, Sofia D., et al. "A Clinicopathological Appraisal of Duodenal Neuroendocrine Tumors at a Racially Diverse Safety Net Hospital." Official journal of the American College of Gastroenterology| ACG 119.7 (2024): 1426-1430.
2. Shaikh, Sofia D., et al. "Irritable bowel syndrome and the gut microbiome: a comprehensive review." Journal of clinical medicine 12.7 (2023): 2558.
3. Burns, Laura, et al. "Report of a novel molecular profile in malignant insulinoma." Journal of Clinical Medicine 12.4 (2023): 1280.
4. Cheng, Kathleen, et al. "Epidemiology of irritable bowel syndrome in a large academic safety-net hospital." Journal of Clinical Medicine 13.5 (2024): 1314.
5. Lee, Christina, et al. "Co-morbidities of irritable bowel syndrome in a racially and ethnically diverse population." Journal of Clinical Medicine 13.5 (2024): 1482.
6. Liu, Jacqueline, et al. "Effects of Sex and Race on Epidemiology and Comorbidities of Patients with Irritable Bowel Syndrome: A Rome III Era Retrospective Study." Diseases 13.5 (2025): 161.
7. Weber, H. Christian, et al. "A bombesin receptor subtype-3 peptide increases nuclear oncogene expression in a MEK-1 dependent manner in human lung cancer cells." European journal of pharmacology 412.1 (2001): 13-20.
8. Jacoba, Isa Mulingbayan, and H. Christian Weber. "Biomarkers in gastroenteropancreatic neuroendocrine neoplasms." Current Opinion in Endocrinology, Diabetes and Obesity 30.3 (2023): 175-180.
9. Yu, Rosa Lu, and H. Christian Weber. "Irritable bowel syndrome, the gut microbiome, and diet." Current Opinion in Endocrinology, Diabetes and Obesity 32.3 (2025): 102-107.
10. Huang, Kevin Z., and H. Christian Weber. "Potassium-competitive acid blockers and acid-related disorders." Current Opinion in Endocrinology, Diabetes and Obesity 31.3 (2024): 107-114.
11. Arokiadoss, Abishek, and H. Christian Weber. "Targeted pharmacotherapy of irritable bowel syndrome." Current Opinion in Endocrinology, Diabetes and Obesity 28.2 (2021): 214-221.
12. Aroniadis, Olga C., et al. "Safety and efficacy of fecal microbiota, live-jslm to prevent recurrent Clostridioides difficile infection in participants with irritable bowel syndrome." Infectious Diseases and Therapy 14.9 (2025): 2157-2169.
13. Wang, Hui, et al. "Lack of bombesin receptor–activated protein attenuates bleomycin-induced pulmonary fibrosis in mice." Life Science Alliance 5.11 (2022).
14. Weber, Heinrich C., et al. "Emergency department childhood anaphylaxis presentations in regional/remote Australia." Journal of Paediatrics and Child Health 58.8 (2022): 1407-1413.
15. Burns, Laura, et al. "Report of a novel molecular profile in malignant insulinoma." Journal of Clinical Medicine 12.4 (2023): 1280.

Profile Details
https://www.bumc.bu.edu/camed/profile/h-weber/
https://connects.catalyst.harvard.edu/Profiles/display/Person/89475
https://www.researchgate.net/profile/Horst-Weber-4